These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. NOTCH1 mutations are associated with favourable long-term prognosis in paediatric T-cell acute lymphoblastic leukaemia: a retrospective study of patients treated on BCH-2003 and CCLG-2008 protocol in China. Gao C; Liu SG; Zhang RD; Li WJ; Zhao XX; Cui L; Wu MY; Zheng HY; Li ZG Br J Haematol; 2014 Jul; 166(2):221-8. PubMed ID: 24690100 [TBL] [Abstract][Full Text] [Related]
5. Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia. La Starza R; Lettieri A; Pierini V; Nofrini V; Gorello P; Songia S; Crescenzi B; Te Kronnie G; Giordan M; Leszl A; Valsecchi MG; Aversa F; Basso G; Biondi A; Conter V; Cazzaniga G; Mecucci C Leuk Res; 2013 Aug; 37(8):928-35. PubMed ID: 23735857 [TBL] [Abstract][Full Text] [Related]
6. T-Cell Receptor Rearrangements Determined Using Fragment Analysis in Patients With T-Acute Lymphoblastic Leukemia. Kim H; Kim IS; Chang CL; Kong SY; Lim YT; Kong SG; Cho EH; Lee EY; Shin HJ; Park HJ; Eom HS; Lee H Ann Lab Med; 2019 Mar; 39(2):125-132. PubMed ID: 30430774 [TBL] [Abstract][Full Text] [Related]
13. [Characteristics of T cell receptor beta gene rearrangements and its role in minimal residual disease detection in childhood T-cell acute lymphoblastic leukemia]. Liu JY; Li ZG; Gao C; Cui L; Wu MY Zhonghua Er Ke Za Zhi; 2008 Jul; 46(7):487-92. PubMed ID: 19099802 [TBL] [Abstract][Full Text] [Related]
14. Gene mutations and pretransplant minimal residual disease predict risk of relapse in adult patients after allogeneic hematopoietic stem-cell transplantation for T cell acute lymphoblastic leukemia. Xu M; Liu H; Liu Y; Ma X; Qiu H; Fu C; Tang X; Han Y; Chen S; Wu D; Sun A Leuk Lymphoma; 2019 Nov; 60(11):2744-2753. PubMed ID: 30950667 [TBL] [Abstract][Full Text] [Related]
15. Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia. Villa-Morales M; Pérez-Gómez L; Pérez-Gómez E; López-Nieva P; Fernández-Navarro P; Santos J Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373496 [TBL] [Abstract][Full Text] [Related]
16. Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia. Hefazi M; Litzow MR Curr Hematol Malig Rep; 2018 Aug; 13(4):265-274. PubMed ID: 29948644 [TBL] [Abstract][Full Text] [Related]
18. New advances in targeting aberrant signaling pathways in T-cell acute lymphoblastic leukemia. Paganelli F; Lonetti A; Anselmi L; Martelli AM; Evangelisti C; Chiarini F Adv Biol Regul; 2019 Dec; 74():100649. PubMed ID: 31523031 [TBL] [Abstract][Full Text] [Related]
19. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Coustan-Smith E; Mullighan CG; Onciu M; Behm FG; Raimondi SC; Pei D; Cheng C; Su X; Rubnitz JE; Basso G; Biondi A; Pui CH; Downing JR; Campana D Lancet Oncol; 2009 Feb; 10(2):147-56. PubMed ID: 19147408 [TBL] [Abstract][Full Text] [Related]
20. The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols. Paganin M; Grillo MF; Silvestri D; Scapinello G; Buldini B; Cazzaniga G; Biondi A; Valsecchi MG; Conter V; Te Kronnie G; Basso G Br J Haematol; 2018 Sep; 182(5):705-711. PubMed ID: 29938780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]